Brain Tumour Research is an official charity partner of Plymouth University. We're one of only four universities in the UK working with the charity to improve the treatment and outcomes of brain tumours.
- brain tumours continue to kill more children and adults under 40 than any other cancer
- there are over 120 different types of brain tumour
- it is estimated that around 16,000 people a year in the UK are diagnosed with a brain tumour
- less than 20 per cent of brain tumour patients survive beyond 5 years of their diagnosis
- 10 people a day die of a brain tumour
Professor Oliver Hanemann discusses his world-leading research into low-grade brain tumours.
Critically underfunded research
These statistics are harsh, whilst the causes of brain tumours are not understood. Less than one per cent are preventable. Brain tumour research is woefully underfunded, receiving just one per cent of the national spend on cancer research. This means a critical lack of researchers to investigate the condition and more effective treatments. At this rate, it could take another 100 years to find a cure.April Watkins, a Plymouth University graduate, was diagnosed with a brain tumour in her first year of study. Read more about her story.
Forging partnerships to accelerate research
In 2014, and following thorough International Peer Review, Plymouth University successfully became one of only four Brain Tumour Research Centres of Excellence in the UK.
The charity is partnering with leading scientists at key universities around the UK to establish, retain, and grow 'world-class' research teams to accelerate progress towards finding a cure.
Building on our strengths
As arguably Europe's leading Neuroscientist investing low-grade brain tumours, the work of Professor Oliver Hanemann is having a profound impact on the potential for effective drug therapies for patients with this condition.
The only current treatments for brain tumours are surgery to remove them or radiotherapy. A unique strength of Oliver's work is 'bench-to-bedside' translational research. The focus is to identify and understand the mechanism underlying the development of brain tumours, and explore ways to halt or reverse that mechanism.
“We have the potential to find a drug therapy and, because we work using a fast-track method, we will get it to patients quickly” – Professor Oliver Hanemann, Director, Institute of Translational and Stratified Medicine
We need your support
It costs £2,740 per day, or £1 million a year to fund our brain tumour research.
Join us in the fight to raise awareness and vital funds by visiting our how-to-give pages and helping further world-leading research in this ‘last battleground against cancer’.
We celebrate and recognise each day of research funded by our supporters, and another step towards finding a cure by placing a tile on our Wall of Hope.
James Greeancre of Plymouth Argyle recently placed a tile after the club raised £2,740 through match day collections, social media and engagement from their players and fans.
Press office news
- Teenage patient’s plea to help fund research for brain tumours 31 March 2017
- Minute’s silence marks the start of Brain Tumour Awareness Month 1 March 2017
- Brain Tumour Research Christmas tree campaign offers hope 15 December 2016
- Lord Mayor of Plymouth visits Plymouth University Brain Tumour Research Centre of Excellence 2 December 2016